LAGOSTA is a Swiss blue biotech company expert in biomedical chitosan production. LAGOSTA farms European spiny lobsters, who during their growth naturally generate molts, who once harvested are converted in chitosan with unparalleled molecular characteristics for biomedical applications.

Products, services, technology

LAGOSTA, thanks to this innovative approach, is the sole company to offer a biomedical chitosan with reproducible biological properties, high molecular weight, high degree of deacetylation as well as EU and US pharmacopoeia compliance.

Cooperation possibilities

If you are seeking reproducible biomedical chitosan with stable biological and physicochemical characteristics from batch to batch to move your programs forward and unlock chitosan’s biomedical potential, offering new treatments to patients worldwide. We look forward to collaborating with you.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Core competencies

You may also be interested in